BioNTech mum on $800M IPO report

Amid a report that it will seek an $800 million IPO, BioNTech told BioCentury it is still evaluating all financial options.

Citing undisclosed people familiar with the IPO, Reuters has reported that BioNTech AG (Mainz, Germany) retained Bank of America and J.P. Morgan as global coordinators for a NASDAQ listing, which is planned for 4Q19 or early next year. An IPO of that size would give the biotech a roughly $4 billion valuation, according to the report...